662P Germline mutation detection in a consecutive multidisciplinary cohort of gastrointestinal tumors: Implications for genetic referral pathways
M C de Grandis, E.D.L. Urso, L. Dal Cengio, R. Intini et autres
0 citationsAnnals of Oncology
A.P. dei Tos
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
10Publications signalées
5Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Sarcoma Diagnosis and TreatmentBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchGastrointestinal Tumor Research and TreatmentVascular Tumors and Angiosarcomas
Publications récentes
516P Discordance in hormone receptor status between primary and recurrent HER2+ breast cancer
M. Bottosso, G. Griguolo, G. Landa, G. Bonomi et autres
0 citationsESMO Open
70P Modulation of the prognostic role of stromal tumor-infiltrating-lymphocytes by tumor proliferation in triple-negative breast cancer: Results from the European GAMBIT network
M.V. Dieci, D. Massa, E. Gasparini, S.O. Giacchetti et autres
0 citationsESMO Open
463P Phenotypic switch in recurrent breast cancer (BC): Patterns and survival benefit of metastatic phenotype-driven treatment
F. Miglietta, C. Vernieri, F. Piacentini, A. Botticelli et autres
0 citationsESMO Open
90P Prognostic factors of soft tissue sarcomas in the real world: A population-based cohort study
Chiara Trevisiol, Alessandra Buja, M. Rugge, Paolo Del Fiore et autres
0 citationsESMO rare cancers.
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease
Claudia Giani, G.G. Baldi, Silva Ljevar, RA Denu et autres
0 citationsESMO Open
Clinical Management and Oncological Outcomes of Pure Pleomorphic and Florid Lobular Carcinoma in Situ of the Breast: Results from the MULTILCIS/OPBC International Multicentric Study
Massimo Ferrucci, Daniele Passeri, Francesco Milardi, L. Middleton et autres
0 citationsEuropean Journal of Surgical Oncology
Corrigendum to “SELNET clinical practice guidelines for soft tissue sarcoma and GIST” [Cancer Treat. Rev. 102 (2021) 102312]
Jean‐Yves Blay, N. Hindi, J. Bollard, S. Aguiar et autres
5 citationsCancer Treatment Reviews
Histology and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS).
P. G. Casali, S. Stacchiotti, P. Verderio, P. Collini et autres
0 citationsJournal of Clinical Oncology
PALETTE: A randomized, double-blind phase III trial of pazopanib versus placebo in patients with soft-tissue sarcoma (STS) whose disease has progressed during or following prior chemotherapy—An EORTC STBSG Global Network Study (EORTC 62072).
Winette T.A. van der Graaf, Jean‐Yves Blay, S. P. Chawla, D. Kim et autres
0 citationsJournal of Clinical Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.